Cryoport Inc.

Cryoport, Inc. provides temperature-controlled supply chain solutions for the life sciences industry, supporting the development and delivery of cell and gene therapies and other medical advances. The company describes itself as a global leader in this field, with decades of experience and a worldwide network spanning the Americas, EMEA and APAC. Its more than 15 locations and team of over 700 experts serve biopharmaceutical, animal husbandry and reproductive medicine companies, as well as universities, research institutions and government agencies.

Cryoport’s family of business units combines supply-chain technologies and services. Cryoport Systems provides globally integrated, temperature-controlled supply chain support for life sciences. MVE Biological Solutions manufactures cryogenic storage and shipper systems, serving the sector for more than half a century. CRYOGENE is a U.S.-based medical biorepository focused on secure storage of biological research specimens and related supplies. Together, these capabilities support clinical trials and commercial therapies, including regenerative medicine, while also offering biostorage and sample processing services. Cryoport, Inc. is publicly traded on NASDAQ under the ticker CYRX.